AI Summary
Thinking
Thinking
We reviewed 12 live results for antibody analysis and narrowed them down to the 3 options that look most worth comparing first.
The options are Myositis-Specific 11 Antibody Panel, YIPF5 Antibody and Roots Analysis.
Source: Mito Health
Description
Myositis-Specific 11 Antibody Panel by Mito Health is a specialized diagnostic blood test designed to identify inflammatory muscle disease subtypes, including polymyositis and dermatomyositis. The panel analyzes eleven autoantibodies—EJ, Jo-1, MDA5, Mi-2 alpha, Mi-2 beta, MJ, OJ, PL-12, PL-7, SRP, and TIF1-gamma—to assess muscle inflammation, associated skin manifestations, and interstitial lung disease involvement. Testing is fulfilled via blood draw at CLIA/CAP-accredited partner laboratories across forty-seven US states and Washington, DC, with clinician-reviewed results delivered digitally.
Best for
Individuals experiencing progressive proximal muscle weakness, Patients with dermatomyositis skin signs or unexplained interstitial lung disease, Confirming and subtyping inflammatory myopathy and Investigating autoimmune causes of elevated muscle enzymes
Rate this product
Source: Novatein Biosciences
Description
The YIPF5 Antibody from Novatein Biosciences (Catalog # SH-A16881) is an antigen affinity-purified rabbit polyclonal primary IgG antibody targeting human Yip1 domain family member 5 (YIPF5). Supplied at a concentration of 200 ug/mL in a 100 uL volume with PBS, 0.1% sodium azide, and 50% glycerol, this antibody is validated for ELISA and Western Blot applications with species reactivity across human, mouse, and rat samples for laboratory research use.
Best for
life science researchers, laboratory scientists, Western blot assays and ELISA detection
Rate this product
Source: Unknown source
Description
Roots Analysis is a specialized market research and business consulting firm focusing on the pharmaceutical, biotechnology, and healthcare sectors. The organization produces in-depth industry intelligence reports, market landscape assessments, and long-term forecasts covering areas such as allogeneic cell therapies, CAR-T, TIL therapies, and novel immunotherapies. Roots Analysis provides commercial insights, pipeline analyses, and competitive intelligence to help healthcare decision-makers, executives, and investors identify emerging market opportunities.
Best for
Biotech Executives, Healthcare Investors, Evaluating cell therapy market landscapes and Conducting biopharmaceutical competitive intelligence
Rate this product
| Compare | #1Myositis-Specific 11 Antibody Panel | #2YIPF5 Antibody | #3Roots Analysis |
|---|---|---|---|
| Source | Mito Health | Novatein Biosciences | Unknown source |
| Description | Myositis-Specific 11 Antibody Panel by Mito Health is a specialized diagnostic blood test designed to identify inflammatory muscle disease subtypes, including polymyositis and dermatomyositis. The panel analyzes eleven autoantibodies—EJ, Jo-1, MDA5, Mi-2 alpha, Mi-2 beta, MJ, OJ, PL-12, PL-7, SRP, and TIF1-gamma—to assess muscle inflammation, associated skin manifestations, and interstitial lung disease involvement. Testing is fulfilled via blood draw at CLIA/CAP-accredited partner laboratories across forty-seven US states and Washington, DC, with clinician-reviewed results delivered digitally. | The YIPF5 Antibody from Novatein Biosciences (Catalog # SH-A16881) is an antigen affinity-purified rabbit polyclonal primary IgG antibody targeting human Yip1 domain family member 5 (YIPF5). Supplied at a concentration of 200 ug/mL in a 100 uL volume with PBS, 0.1% sodium azide, and 50% glycerol, this antibody is validated for ELISA and Western Blot applications with species reactivity across human, mouse, and rat samples for laboratory research use. | Roots Analysis is a specialized market research and business consulting firm focusing on the pharmaceutical, biotechnology, and healthcare sectors. The organization produces in-depth industry intelligence reports, market landscape assessments, and long-term forecasts covering areas such as allogeneic cell therapies, CAR-T, TIL therapies, and novel immunotherapies. Roots Analysis provides commercial insights, pipeline analyses, and competitive intelligence to help healthcare decision-makers, executives, and investors identify emerging market opportunities. |
| Best for | Individuals experiencing progressive proximal muscle weakness, Patients with dermatomyositis skin signs or unexplained interstitial lung disease, Confirming and subtyping inflammatory myopathy and Investigating autoimmune causes of elevated muscle enzymes | life science researchers, laboratory scientists, Western blot assays and ELISA detection | Biotech Executives, Healthcare Investors, Evaluating cell therapy market landscapes and Conducting biopharmaceutical competitive intelligence |
| Action | Mito Health | Novatein Biosciences | Roots Analysis |
| Rate this product |
"Myositis-Specific 11 Antibody Panel from Mito Health."
Note: TopFind AI compiles product and service information for general comparison purposes only.
